The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1–Mediated Inhibition
Open accessAbstract
Although CD4 T cells are required for host resistance to Mycobacterium tuberculosis, they may also contribute to pathology. In this study, we examine the role of the inhibitory receptor PD-1 and its ligand PD-L1 during M. tuberculosis infection. After aerosol exposure, PD-1 knockout (KO) mice develop high numbers of M. tuberculosis-specific CD4 T cells but display markedly increased susceptibility to infection. Importantly, we show that CD4 T cells themselves drive the increased bacterial loads and pathology seen in infected PD-1 KO mice, and PD-1 deficiency in CD4 T cells is sufficient to trigger early mortality. PD-L1 KO mice also display enhanced albeit less severe susceptibility, indicating that T cells are regulated by multiple PD ligands during M. tuberculosis infection. M. tuberculosis-specific CD8 T cell responses were normal in PD-1 KO mice, and CD8 T cells only had a minor contribution to the exacerbated disease in the M. tuberculosis-infected PD-1 KO and PD-L1 KO mice. Thus, in the absence of the PD-1 pathway, M. tuberculosis benefits from CD4 T cell responses, and host resistance requires inhibition by PD-1 to prevent T cell-driven exacerbation of the infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and Its Ligands in Tolerance and Immunity
Keir, M. E., Butte, M. J., Freeman, G. J., & Sharpe, A. H. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090331 · Cited by 5,378
Self-citationFreeman, G. J., Long, A. J., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., Fitz, L. J., Malenkovich, N., Okazaki, T., Byrne, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1027 · Cited by 5,294
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Self-citationTuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent
Keane, J., Gershon, S., Wise, R. P., Mirabile-Levens, E., Kasznica, J., Schwieterman, W. D., Siegel, J. N., & Braun, M. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011110 · Cited by 3,710
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
Latchman, Y., Wood, C. R., Chernova, T., Chaudhary, D., Borde, M., Chernova, I., Iwai, Y., Long, A. J., Brown, J. A., Nunes, R., et al. (2001) · Nature Immunology · doi:10.1038/85330 · Cited by 2,955
Self-citationPD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Dong, H., Zhu, G., Tamada, K., & Chen, L. (1999) · Nature Medicine · doi:10.1038/70932 · Cited by 2,496
Disseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
Butte, M. J., Keir, M. E., Phamduy, T. B., Sharpe, A. H., & Freeman, G. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.016 · Cited by 1,732
Self-citationFlynn, J. L., Goldstein, M. M., Chan, J., Triebold, K. J., Pfeffer, K., Lowenstein, C. J., Schrelber, R., Mak, T. W., & Bloom, B. R. (1995) · Immunity · doi:10.1016/1074-7613(95)90001-2 · Cited by 1,677
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
Boni, C., Fisicaro, P., Valdatta, C., Amadei, B., Di Vincenzo, P., Giuberti, T., Laccabue, D., Zerbini, A., Cavalli, A., Missale, G., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02844-06 · Cited by 920
PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection
Petrovas, C., Casazza, J. P., Brenchley, J. M., Price, D. A., Gostick, E., Adams, W. C., Precopio, M. L., Schacker, T., Roederer, M., Douek, D. C., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061496 · Cited by 889
B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells
Tseng, S.-Y., Otsuji, M., Gorski, K., Huang, X., Slansky, J. E., Pai, S. I., Shalabi, A., Shin, T., Pardoll, D. M., & Tsuchiya, H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.7.839 · Cited by 872
Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency
Altare, F., Durandy, A., Lammas, D., Emile, J.-F., Lamhamedi, S., Le Deist, F., Drysdale, P., Jouanguy, E., Döffinger, R., Bernaudin, F., et al. (1998) · Science · doi:10.1126/science.280.5368.1432 · Cited by 845
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., Vanderford, T. H., Chennareddi, L., Silvestri, G., Freeman, G. J., et al. (2009) · Nature · doi:10.1038/nature07662 · Cited by 771
Cooper, A. M., Magram, J., Ferrante, J., & Orme, I. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.39 · Cited by 715
Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
Comas, I., Chakravartti, J., Small, P. M., Galagan, J., Niemann, S., Kremer, K., Ernst, J. D., & Gagneux, S. (2010) · Nature Genetics · doi:10.1038/ng.590 · Cited by 707
Urbani, S., Amadei, B., Tola, D., Massari, M., Schivazappa, S., Missale, G., & Ferrari, C. (2006) · Journal of Virology · doi:10.1128/jvi.01177-06 · Cited by 588
Caruso, A. M., Serbina, N. V., Klein, E. C., Triebold, K. J., Bloom, B. R., & Flynn, J. L. (1999) · PubMed · Cited by 489
Mayer-Barber, K. D., Barber, D. L., Shenderov, K., White, S. D., Wilson, M. S., Cheever, A., Kugler, D., Hieny, S., Caspar, P., Núñez, G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904189 · Cited by 478
Self-citationEvasion of innate immunity by Mycobacterium tuberculosis: is death an exit strategy?
Behar, S. M., Divangahi, M., & Remold, H. G. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2387 · Cited by 435
Caruso, A. M., Serbina, N., Klein, E., Triebold, K., Bloom, B. R., & Flynn, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5407 · Cited by 418
Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis
Chan, J., Tanaka, K., Carroll, D., Flynn, J., & Bloom, B. R. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.736-740.1995 · Cited by 407
PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver
Iwai, Y., Terawaki, S., Ikegawa, M., Okazaki, T., & Honjo, T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022235 · Cited by 392
Lethal tuberculosis in interleukin-6-deficient mutant mice
Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K., Kopf, M., & Kaufmann, S. H. (1997) · Infection and Immunity · doi:10.1128/iai.65.11.4843-4849.1997 · Cited by 358
Scanga, C. A., Mohan, V. P., Yu, K., Joseph, H., Tanaka, K., Chan, J., & Flynn, J. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.347 · Cited by 350
Fremond, C. M., Togbe, D., Doz, E., Rose, S., Vasseur, V., Maillet, I., Jacobs, M., Ryffel, B., & Quesniaux, V. F. J. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.1178 · Cited by 338
Programmed death-1 (PD-1)–deficient mice are extraordinarily sensitive to tuberculosis
Lázár-Molnár, E., Chen, B., Sweeney, K. A., Wang, E. J., Liu, W., Lin, J., Porcelli, S. A., Almo, S. C., Nathenson, S. G., & Jacobs, W. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007394107 · Cited by 338
Shafiani, S., Tucker-Heard, G., Kariyone, A., Takatsu, K., & Urdahl, K. B. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091885 · Cited by 308
Perlman, D. C., El‐Sadr, W. M., Nelson, E. T., Matts, J. P., Telzak, E. E., Salomon, N., Chirgwin, K., & Hafner, R. (1997) · Clinical Infectious Diseases · doi:10.1086/514546 · Cited by 295
Immune evasion by Mycobacterium tuberculosis: living with the enemy
Flynn, J. L., & Chan, J. (2003) · Current Opinion in Immunology · doi:10.1016/s0952-7915(03)00075-x · Cited by 283
Cruz, A., Fraga, A. G., Fountain, J. J., Rangel-Moreno, J., Torrado, E., Saraiva, M., Pereira, D. R., Randall, T. D., Pedrosa, J., Cooper, A. M., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100265 · Cited by 256
Defects in the interferon‐γ and interleukin‐12 pathways
Rosenzweig, S. D., & Holland, S. M. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00227.x · Cited by 219
Protective Role of Interleukin-1 in Mycobacterial Infection in IL-1 α/β Double-Knockout Mice
Yamada, H., Mizumo, S., Horai, R., Iwakura, Y., & Sugawara, I. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780079 · Cited by 209
PD-1 on dendritic cells impedes innate immunity against bacterial infection
Yao, S., Wang, S., Zhu, Y., Luo, L., Zhu, G., Flies, S., Xu, H., Ruff, W., Broadwater, M., Choi, I.-H., et al. (2009) · Blood · doi:10.1182/blood-2009-02-203141 · Cited by 208
Memory CD4+ T cells induce innate responses independently of pathogen
Strutt, T. M., McKinstry, K. K., Dibble, J. P., Winchell, C., Kuang, Y., Curtis, J. D., Huston, G., Dutton, R. W., & Swain, S. L. (2010) · Nature Medicine · doi:10.1038/nm.2142 · Cited by 195
Delayed protection by ESAT-6–specific effector CD4+ T cells after airborne M. tuberculosis infection
Gallegos, A. M., Pamer, E. G., & Glickman, M. S. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080353 · Cited by 194
Lang, R., Rutschman, R. L., Greaves, D. R., & Murray, P. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3402 · Cited by 169
Mueller, S. N., Vanguri, V. K., Ha, S.-J., West, E. E., Keir, M. E., Glickman, J. N., Sharpe, A. H., & Ahmed, R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40040 · Cited by 160
Self-citationWhat's good for the host is good for the bug
Flynn, J. L., & Chan, J. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.01.005 · Cited by 151
Sullivan, B. M., Jobe, O., Lazarevic, V., Vasquez, K. O., Bronson, R. T., Glimcher, L. H., & Kramnik, I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4593 · Cited by 142
Jung, Y., Ryan, L., LaCourse, R., & North, R. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050265 · Cited by 136
Lázár‐Molnár, E., Gácser, A., Freeman, G. J., Almo, S. C., Nathenson, S. G., & Nosanchuk, J. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711918105 · Cited by 125
Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire
Mukadi, Y. D., Perriëns, J., Louis, M. E. S., Brown, C., Ryder, R. W., Perriëns, J. H., Portaels, F., Piot, P., Perriëns, J. H., Willame, J.-C., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)91346-n · Cited by 122
B7‐H1 (CD274) inhibits the development of herpetic stromal keratitis (HSK)
Her, J., Seo, S. K., Jeong, H.-Y., Seo, H.-M., Zhu, G., Chen, L., & Choi, I.-H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.098 · Cited by 47
Contrasting persistence strategies in Salmonella and Mycobacterium
Tischler, A. D., & McKinney, J. D. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.12.007 · Cited by 29
Cited by
Pai, M., Behr, M. A., Dowdy, D., Dheda, K., Divangahi, M., Boehme, C. C., Ginsberg, A., Swaminathan, S., Spigelman, M., Getahun, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.76 · Cited by 1,270
The immunological life cycle of tuberculosis
Ernst, J. D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3259 · Cited by 577
Immune checkpoint blockade in infectious diseases
Wykes, M. N., & Lewin, S. R. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.112 · Cited by 570
The foundations of immune checkpoint blockade and the ipilimumab approval decennial
Korman, A. J., Garrett-Thomson, S. C., & Lonberg, N. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00345-8 · Cited by 548
Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection
Butler, N. S., Moebius, J., Pewe, L. L., Traore, B., Doumbo, O. K., Tygrett, L. T., Waldschmidt, T. J., Crompton, P. D., & Harty, J. T. (2012) · Nature Immunology · doi:10.1038/ni.2180 · Cited by 482
Metadata
- Authors
- Barber, D. L., Mayer-Barber, K. D., Feng, C. G., Sharpe, A. H., & Sher, A.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-01
- Volume
- 186
- Issue
- 3
- Pages
- 1598-1607
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2099717852
- Cited by
- 329
- References
- 48
- FWCI
- 7.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.